Capecitabine
Cardiac Disease
Odense University HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Cardiac Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acetylsalicylic Acid Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Ticagrelor Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
COLCHICINUM Assistance Publique - Hôpitaux de Paris | Phase 3 | B |
Indocyanine Green University of Foggia | D |
Same molecule, other indications
Capecitabine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →